← Open Payments lookup

ALEXANDRIA BONNER: Open Payments

NPI 1427575489 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$794 in 43 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $794

Food & beverage: $794
CompanyPaymentsAmount
ABBVIE INC.15$195
Vanda Pharmaceuticals Inc.3$80
Neurocrine BioSciences, Inc.3$80
Alkermes, Inc.3$67
Janssen Pharmaceuticals, Inc3$55
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
Otsuka America Pharmaceutical, Inc.2$47
Teva Pharmaceuticals USA, Inc.2$39
Axsome Therapeutics, Inc.2$33
MDD US Operations, LLC2$33

Products named: VRAYLAR, FANAPT, INGREZZA, ARISTADA, CAPLYTA, REXULTI, UZEDY, Auvelity.

Industry payments across IA — which companies pay providers there.